Evidence map›Paper›PMID 39417927›Full record

ArticleHead and neck pathology2024

Comprehensive Next Generation Sequencing Reveals that Purported Primary Squamous Cell Carcinomas of the Parotid Gland are Genetically Heterogeneous.

Justin A Bishop, Masato Nakaguro, Ilan Weinreb, Doreen Palsgrove, Lisa M Rooper, Travis W Vandergriff, Brian Carlile, Jeffrey A Sorelle, Jeffrey Gagan, Toshitaka Nagao

Abstract read
In one paragraph

Article in Head and neck pathology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Justin A BishopDepartment of Pathology, UT Southwestern Medical Center, Dallas, TX, USA. Justin.A.Bishop@UTSouthwestern.edu.
Masato NakaguroDepartments of Pathology and Laboratory Medicine, Nagoya University Hospital, Nagoya, Japan.
Ilan WeinrebDepartment of Pathology, University Health Network and the University of Toronto, Toronto, ON, Canada.
Doreen PalsgroveDepartment of Pathology, UT Southwestern Medical Center, Dallas, TX, USA.
Lisa M RooperDepartments of Pathology and Oncology, The Johns Hopkins Medical Institutions, Baltimore, MD, USA.
Travis W VandergriffDepartment of Pathology, UT Southwestern Medical Center, Dallas, TX, USA.
Brian CarlileDepartment of Pathology, Baylor Scott and White Health, All Saints Medical Center, Fort Worth, TX, USA.
Jeffrey A SorelleDepartment of Pathology, UT Southwestern Medical Center, Dallas, TX, USA.
Jeffrey GaganDepartment of Pathology, UT Southwestern Medical Center, Dallas, TX, USA.
Toshitaka NagaoDepartment of Anatomic Pathology, Tokyo Medical University, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Squamous cell carcinoma (SCC) is one of the most common malignancies involving the parotid gland, but it has been recognized that the vast majority of parotid SCC represents metastases, especially from the ipsilateral facial skin. Bona fide primary SCC of the parotid is so rare that it is unclear whether it truly exists at all. We sought to molecularly characterize cases diagnosed as primary parotid gland SCC to see if they possess a unique genetic makeup.We identified cases in our archives which had been diagnosed as primary SCC of the parotid gland. In all cases, metastatic disease was excluded by a thorough history and physical examination. Cases with histologic evidence of a precursor neoplasm (e.g., carcinoma ex-pleomorphic adenoma) were also excluded. Targeted next-generation sequencing (NGS) was attempted on all cases.Six cases diagnosed as primary parotid SCC were identified, arising in 4 males and 2 females ranging from 8 to 73 years (mean, 51.8 years). All cases exhibited keratinization and unequivocal invasion. Four of 6 appeared to be arising from cystically dilated ducts. Five of 6 exhibited well-developed cellular atypia; the remaining case, while cytologically bland, demonstrated perineural invasion. Targeted NGS was successful in 5 of 6 cases. Two SCC harbored several mutations in a mutational profile reminiscent of SCCs seen in other organs. One case harbored YAP1::MAML2, a fusion previously reported in porocarcinoma and other neoplasms. One case harbored IRF2BP2::RUNX2, and presumably represents keratocystoma or SCC ex-keratocystoma. Finally, one case an increase of C > T mutations consistent with ultraviolet damage, suggesting that this case represented a cryptic metastasis from cutaneous SCC.Our analysis did not confirm a unifying genetic signature for purported primary parotid SCC. Indeed, our findings suggest that true primary parotid gland SCC is even rarer than already believed. In our 5 cases with results, NGS findings demonstrated that one was likely a keratocystoma, one a cryptic metastasis from a cutaneous SCC, and one a porocarcinoma, either metastatic or primary. The two remaining cases had complex genotypes reminiscent of SCCs from other sites. This may be the signature of genuine parotid primary SCC, but metastasis from an SCC from another organ cannot be excluded. Accordingly, a diagnosis of primary parotid gland SCC should be viewed with skepticism.

Indexed as

High-Throughput Nucleotide SequencingParotid NeoplasmsAdolescentAdultAgedBiomarkers, TumorCarcinoma, Squamous CellChildFemaleHumansMaleMiddle AgedSquamous Cell Carcinoma of Head and NeckYoung AdultBiomarkers, TumorIRF2BP2KeratocystomaMAML2Parotid GlandRUNX2Squamous cell CarcinomaTP53YAP1

Identifiers

PMID39417927
PMCPMC11486867

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.